
Cistron Therapeutics is a biotechnology company focused on revolutionizing cancer treatment through AI-powered drug discovery. They specialize in identifying small molecule peptides and natural products that target difficult-to-treat oncogenic proteins. Their proprietary AI platform analyzes drug interactions with specific cancer targets, enabling the design and screening of personalized therapies. The company actively seeks collaborations with academic institutions, research centers, and pharmaceutical companies to accelerate its drug discovery efforts. Cistron Therapeutics aims to address complex disease targets that are often overlooked by traditional methods, with a vision to become a leader in AI-driven drug discovery for challenging diseases.

Cistron Therapeutics is a biotechnology company focused on revolutionizing cancer treatment through AI-powered drug discovery. They specialize in identifying small molecule peptides and natural products that target difficult-to-treat oncogenic proteins. Their proprietary AI platform analyzes drug interactions with specific cancer targets, enabling the design and screening of personalized therapies. The company actively seeks collaborations with academic institutions, research centers, and pharmaceutical companies to accelerate its drug discovery efforts. Cistron Therapeutics aims to address complex disease targets that are often overlooked by traditional methods, with a vision to become a leader in AI-driven drug discovery for challenging diseases.